Private company
Eleusis
Logo: https://mms.businesswire.com/media/20220120005418/en/1333836/23/Eleusis_HorizontalLogo_Color.jpg, Non-free logo, via Wikipedia3
British pharmaceutical company
Eleusis is a pharmaceutical company that is developing serotonin 5-HT2A receptor agonists related to serotonergic psychedelics as novel anti-inflammatory drugs to treat inflammatory diseases. It is interested in developing the drugs for treatment of conditions like asthma, cardiovascular disease, and Crohn's disease, but is initially focusing on ophthalmology.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
See how the biggest companies compare on our leaderboards
Eleusis is a pharmaceutical company that is developing serotonin 5-HT2A receptor agonists related to serotonergic psychedelics as novel anti-inflammatory drugs to treat inflammatory diseases. It is interested in developing the drugs for treatment of conditions like asthma, cardiovascular disease, and Crohn's disease, but is initially focusing on ophthalmology.2
Links
- LinkedInwww.linkedin.com/company/eleusisl1
- WikipediaEleusis (company)
- WikidataQ132891360
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataEleusis on Wikidata
- 2WikipediaEleusis on Wikipedia
- 3